Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(22%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
1
11%
Ph not_applicable
5
56%
Ph phase_4
2
22%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 4Post-market surveillance
2(25.0%)
N/ANon-phased studies
5(62.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(3)
Completed(6)

Detailed Status

Completed6
Recruiting1
Active, not recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (12.5%)
Phase 42 (25.0%)
N/A5 (62.5%)

Trials by Status

recruiting111%
active_not_recruiting111%
not_yet_recruiting111%
completed667%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
PROCEDURE
Total Trials
9